Bilirubin is a pigment produced when the body breaks down old red blood cells. The liver processes bilirubin for excretion into bile. Total bilirubin measures both the unprocessed (indirect) and processed (direct) forms together.
Elevated total bilirubin can indicate liver dysfunction, bile duct obstruction, or increased red blood cell breakdown. Mildly elevated bilirubin with no other abnormalities often reflects Gilbert's syndrome, a benign genetic variant affecting roughly 5-10% of the population that's associated with better cardiovascular outcomes and longer life. Interpretation is most meaningful when indirect and direct fractions are measured separately.
Optimal Bilirubin Total: 0.2-1 mg/dL.
Typically re-tested every 12 weeks.
Total bilirubin is a blood test that measures all the bilirubin circulating in your serum, both the unconjugated (indirect) form still waiting to be processed and the conjugated (direct) form the liver has already prepared for excretion.
The mechanism is worth understanding, because it explains almost everything a result can tell you. Red blood cells have a finite lifespan. When they are retired, the heme inside them is broken down into biliverdin and then into bilirubin. That freshly made bilirubin is fat soluble and poorly water soluble, so it travels through the bloodstream bound to albumin. It reaches the liver, where an enzyme attaches glucuronic acid to it. That step, called conjugation, makes the molecule water soluble so it can be pushed into bile, carried into the intestine and eliminated.
So a total bilirubin result sits at the end of a three-stage assembly line. Stage one is production, how much heme is being broken down. Stage two is liver uptake and conjugation. Stage three is bile flow, whether the finished product can actually leave. A total value that is higher than expected means one of those three stages is out of step, and the split between direct and indirect bilirubin is the clue to which one. That is why clinical guidance on abnormal liver chemistries treats bilirubin as one piece of a pattern rather than a standalone verdict[1].
It matters because it is one of the few inexpensive, widely available markers that reports on red blood cell turnover, liver function and bile drainage at the same time.
For most healthy adults, total bilirubin is a quiet marker. It sits in a narrow band year after year, and its main value is as a baseline. A stable number across repeat testing tells you the three stages above are working. A number that drifts upward over time, especially alongside changes in liver enzymes, is a prompt to look closer rather than an answer in itself.
In the setting of illness, bilirubin becomes more informative. Research examining liver biochemical parameters during acute illness has found that elevated bilirubin is associated with worse outcomes, including in hospitalized patients with COVID-19[2]. In advanced liver disease, bilirubin is one of the parameters studied for its ability to predict short-term prognosis, and work on serum metabolomic patterns in acute-on-chronic liver failure has examined bilirubin alongside other markers for ninety-day prognostic value[3]. Bilirubin is also used as a recovery measure in surgical research, for example in meta-analysis of postoperative outcomes after liver resection[4]. None of that applies to a mildly raised value in an otherwise well person, but it explains why clinicians take a rising bilirubin seriously when someone is unwell.
Bilirubin also behaves as an antioxidant in laboratory settings. Whether people with naturally higher values within the normal band have different cardiovascular risk is not established, and no reputable source recommends trying to raise your bilirubin.
For adults, a typical lab reference range for total bilirubin is 0.1 to 1.2 mg/dL, and FitScript's optimal range is 0.2 to 1 mg/dL.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Total bilirubin, adults | 0.1 to 1.2 mg/dL | 0.2 to 1 mg/dL |
Total bilirubin runs higher in men than in women. In 23,597 healthy adults the upper limit for men rose after 60, while women's stayed about the same.[13][14]
| Sex | Age | Reference range (μmol/L) |
|---|---|---|
| Men | 18 to 59 | 8.4 to 32.1 |
| Men | 60 and over | 9.0 to 35.7 |
| Women | 18 to 59 | 7.2 to 27.5 |
| Women | 60 and over | 8.0 to 27.1 |
In mg/dL, a large laboratory study found 0.32 to 1.30 in men and 0.28 to 1.04 in women aged 19 and over.[14] Your own lab's printed range is the one to read your result against.
Reference ranges vary by laboratory, assay, age and sex, so always read your result against the range printed on your own report. FitScript's optimal range is an optimization target used to frame where a result sits within normal, not a diagnostic cut-off and not a threshold for treatment.
A few practical notes on reading the number. Some labs report in µmol/L rather than mg/dL, and the two are related by a fixed conversion factor, so a value that looks alarming may simply be in different units. Most reports also break the total into direct and indirect fractions, and in adults the direct fraction is normally the smaller share of the total. Newborns are a separate category entirely, with their own age-in-hours thresholds and their own clinical pathways, because the infant liver is still ramping up its conjugating capacity[5]. Research on predicting bilirubin neurotoxicity in jaundiced newborns is a distinct body of work and the thresholds from it do not transfer to adult interpretation[6].
A high total bilirubin means bilirubin is being produced faster than it can be processed and excreted, and the direct-versus-indirect split, plus the liver enzyme pattern, points to where the bottleneck sits.
What people notice. Mild elevations usually produce nothing at all, which is why they are so often found incidentally on routine bloodwork. As values climb, some people report yellowing of the whites of the eyes, then of the skin, darker urine, paler stools, itching, fatigue, or a vague sense of being off. Some people with a lifelong mild elevation notice it only when they are fasting, dehydrated, sleep deprived or fighting an infection.
Common reasons a value runs high.
Why it is followed over time. A single mildly raised value in a well person is usually repeated rather than acted on. What matters is the pattern. Guideline-based evaluation of abnormal liver chemistries works from the combination of bilirubin, aminotransferases and alkaline phosphatase, the degree of elevation and the clinical picture, rather than from one number[1]. A persistently suboptimal or rising result, or one paired with abnormal enzymes, is worth discussing with a clinician so the cause can be identified. Visible jaundice with fever, severe abdominal pain, vomiting, confusion or dark urine is worth discussing with a clinician promptly rather than waiting for the next scheduled test.
A low total bilirubin is rarely treated as a clinical problem, and in most cases it reflects normal physiology, a laboratory's lower detection limit, or how the sample was handled.
What people notice. Nothing. There is no recognized symptom set attributable to a low total bilirubin, and no established syndrome of bilirubin deficiency.
Common reasons a value runs low. Natural variation accounts for most of it, since some people simply sit at the bottom of the normal band. Lower red cell turnover, pregnancy and certain medications that increase the activity of liver enzymes involved in clearance can nudge the number down. Pre-analytical factors matter too, because bilirubin is light sensitive and degrades in a sample left exposed or processed late, and systematic review of pre-analytical variation shows how storage conditions and delays can shift measured analyte values[9].
What it means long term. Whether people in the lower part of the range carry more oxidative stress, given bilirubin's antioxidant behaviour in laboratory settings, is not established, and there is no recognised way, or reason, to deliberately raise a low value. A low result is best read as context for the rest of your panel rather than as a target.
Total bilirubin is more variable than most people expect, and a meaningful share of that variation comes from how and when you were tested rather than from your biology.
Testing conditions. Prolonged fasting can raise unconjugated bilirubin, noticeably so in people with reduced conjugating capacity, so an overnight fast and a non-fasting draw may not give the same number. Dehydration concentrates the sample. Hard exercise in the preceding day or two, acute illness and poor sleep can all move the value. On the laboratory side, a hemolyzed sample, a lipemic sample, light exposure or a delay before processing can all alter the measured result[9]. Testing under consistent conditions, at a similar time of day and with similar prior-day habits, makes a trend readable.
Medications. Several classes of medication can influence bilirubin, by affecting bile flow, by competing for the conjugation pathway, by increasing red cell breakdown, or by inducing enzymes that speed clearance. Liver parameters including bilirubin are also considered in pharmacokinetic research, for example in population pharmacokinetic analyses of investigational agents in cancer patients, where hepatic handling is relevant to how a drug is cleared[10]. Never start, stop or change a prescribed medication because of a lab value. Bring the result and your full medication and supplement list to the clinician who prescribes for you.
Habits. Alcohol intake, overall energy balance, rapid weight loss, and anything that stresses the liver or increases red cell turnover can shift the number. Most of these effects are modest and reversible, which is exactly why repeat testing matters more than a single snapshot.
Total bilirubin is measured on standard serum chemistry panels, usually as part of a comprehensive metabolic or liver-focused panel that reports it alongside the direct fraction, aminotransferases, alkaline phosphatase and albumin.
FitScript is a labs-first membership built around 150+ biomarkers tested per year, so bilirubin is read in company rather than in isolation. Atlas, FitScript's AI health advisor, interprets each result against your own history, the rest of the panel and your reported symptoms, then writes your FitScript. The practical value of repeat testing is trend. One value tells you where you are, several values tell you whether anything is moving, and a stable mild elevation with normal enzymes carries a very different weight from a value that has doubled since last draw. Pattern-based evaluation is the approach clinical guidance takes with abnormal liver chemistries[1].
Where a result points toward a condition that might benefit from treatment, a licensed provider evaluates whether any therapy is appropriate, orders further workup and makes the decision. Medications studied in liver disease, such as ursodeoxycholic acid in nonalcoholic steatohepatitis, have mixed and debated evidence and are prescription decisions, not self-directed ones[11]. Cell-based approaches, such as mesenchymal stem cell therapy examined in pooled analyses of liver disease, remain experimental and clinician-gated[12]. This article is educational and is not medical advice.
Bilirubin is only interpretable next to the markers that separate production, processing and drainage, so these are the ones to read on the same report.
Splitting the total into fractions is the first step, and Direct Bilirubin tells you whether the excess is conjugated (pointing toward bile flow) or unconjugated (pointing toward production or conjugation). Liver cell injury shows up in ALT and AST, while obstruction of bile flow typically raises Alkaline Phosphatase, and GGT helps confirm that an alkaline phosphatase elevation is coming from the biliary system rather than from bone. If the indirect fraction is raised with normal enzymes, Hemoglobin and the rest of the blood count help show whether faster red cell turnover is part of the picture. Because fatty liver disease is closely tied to insulin resistance, the Metabolic + Insulin panel adds the metabolic context that liver enzymes alone do not give.
A total bilirubin value is a snapshot of how well your body makes, processes and excretes one specific pigment, and the number means little without the direct fraction, the liver enzymes and your own baseline next to it. A mildly raised value in a well person is common and frequently benign, a falling or low value is rarely clinically meaningful on its own, and a rising value or one paired with abnormal enzymes deserves a closer look. Testing under consistent conditions and watching the trend will tell you far more than any single draw. Discuss your results, and any treatment you are considering, with a clinician or licensed provider who can see your full history.
It measures all the bilirubin in your serum, which is the pigment produced when red blood cells are broken down and their heme is processed. The total includes the unconjugated (indirect) form the liver has not yet processed and the conjugated (direct) form prepared for excretion into bile.
A typical lab reference range for adults is 0.1 to 1.2 mg/dL, and FitScript's optimal range is 0.2 to 1 mg/dL. Ranges vary by laboratory, assay, age and sex, so compare your result with the range printed on your own report. FitScript's optimal range is an optimization target, not a diagnostic cut-off.
A mildly raised value in someone who feels well is common and is usually repeated before anything else is done, because fasting, dehydration, recent illness, hard exercise and sample handling can all move it. What matters is the pattern over time and how it sits against the direct fraction and liver enzymes. A persistently raised result is worth discussing with a clinician.
The usual categories are faster red blood cell breakdown, reduced capacity to conjugate bilirubin in the liver (Gilbert's syndrome is a common inherited example), obstructed bile flow from causes such as gallstones, liver cell injury from viral, alcohol-related, metabolic or drug-related causes, and certain medications. Only a clinician reviewing your full picture can identify which applies to you.
It can. Prolonged fasting is known to raise unconjugated bilirubin in some people, and the effect is more noticeable in those with reduced conjugating capacity. Dehydration, acute illness and intense recent exercise can also shift the number, which is why testing under consistent conditions makes trends easier to read.
Low values are rarely treated as a clinical concern. They often reflect normal variation, a laboratory's lower detection limit, certain medications, or sample handling, since bilirubin degrades with light exposure and delayed processing. There is no recognized symptom set for low bilirubin and no reason to try to raise it.
Direct bilirubin is the conjugated fraction the liver has already processed and made water soluble, while total bilirubin includes both that fraction and the unconjugated form still bound to albumin. The split between them is the main clue to whether a raised total points toward bile flow or toward production and conjugation.
Direct bilirubin, ALT, AST, alkaline phosphatase, GGT and hemoglobin together separate liver cell injury from bile flow obstruction and from increased red cell turnover. Metabolic markers add context, because fatty liver disease is closely linked to insulin resistance.
That depends on your result and your clinical picture, and the decision belongs to the clinician reviewing your labs. As a principle, an isolated mild abnormality is usually confirmed on a repeat draw, and regular testing over time makes the trend, which is more informative than any single value, visible.